We are live on ! Find out more
ISL

Ingalls & Snyder LLC Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.61%
This Fund
S&P 500
This Quarter Est. Return
+9.1%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$2.14B
AUM Growth
+$116M
Cap. Flow
-$26.7M
Cap. Flow %
-1.25%
Top 10 Hldgs %
33.75%
Holding
461
New
36
Increased
115
Reduced
195
Closed
23

Top Buys

Rank Stock Value
1
DE icon
Deere & Co
DE
+$4.94M
2
STM icon
STMicroelectronics
STM
+$4.34M
3
FROG icon
JFrog
FROG
+$3.94M
4
MO icon
Altria Group
MO
+$3.73M
5
IDN icon
Intellicheck
IDN
+$3.01M

Top Sells

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$9.49M
2
AAPL icon
Apple
AAPL
+$9.19M
3
GM icon
General Motors
GM
+$5.02M
4
GS icon
Goldman Sachs
GS
+$4.66M
5
CSCO icon
Cisco
CSCO
+$3.79M

Sector Composition

Rank Sector Weight
1 Healthcare 22.27%
2 Technology 14.4%
3 Financials 13.66%
4 Energy 11.86%
5 Industrials 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XYL icon
401
Xylem
XYL
$27.3B
$215K 0.01%
2,042
+42
+2% +$4.26K
TTEK icon
402
Tetra Tech
TTEK
$8.49B
$212K 0.01%
+7,825
New +$207K
ANET icon
403
Arista Networks
ANET
$227B
$211K 0.01%
11,200
IWF icon
404
iShares Russell 1000 Growth ETF
IWF
$121B
$210K 0.01%
3,452
-1,480
-30% -$90.1K
FBMS
405
DELISTED
The First Bancshares, Inc.
FBMS
$206K 0.01%
+5,634
New +$189K
SD icon
406
SandRidge Energy
SD
$514M
$205K 0.01%
52,483
-15,000
-22% -$68.3K
TMQ
407
Trilogy Metals
TMQ
$541M
$205K 0.01%
+95,600
New +$207K
BIIB icon
408
Biogen
BIIB
$30B
$201K 0.01%
+720
New +$194K
CIEN icon
409
Ciena
CIEN
$53.4B
$201K 0.01%
+3,680
New +$198K
VRT icon
410
Vertiv
VRT
$93B
$201K 0.01%
+10,073
New +$203K
UHS icon
411
Universal Health Services
UHS
$10.2B
$200K 0.01%
1,500
ABCM
412
DELISTED
Abcam PLC
ABCM
$192K 0.01%
10,000
ZNGA
413
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$161K 0.01%
+15,800
New +$165K
NMY
414
DELISTED
Nuveen Maryland Quality Municipal Income Fund
NMY
$156K 0.01%
11,000
SJT
415
San Juan Basin Royalty Trust
SJT
$117M
$148K 0.01%
37,376
RDHL
416
Redhill Biopharma
RDHL
$3.95M
$143K 0.01%
19
VRRM icon
417
Verra Mobility
VRRM
$804M
$143K 0.01%
10,534
+281
+3% +$3.9K
LUNA
418
DELISTED
Luna Innovations Incorporated
LUNA
$129K 0.01%
12,215
CSBR icon
419
Champions Oncology
CSBR
$74.5M
$125K 0.01%
11,056
-6,000
-35% -$69.6K
LUXAW
420
DELISTED
Lux Health Tech Acquisition Corp. Warrants
LUXAW
$103K ﹤0.01%
+70,550
New +$178K
SCOR icon
421
Comscore
SCOR
$106M
$100K ﹤0.01%
1,368
FOREU
422
DELISTED
Foresight Acquisition Corp. Units
FOREU
$99K ﹤0.01%
+10,000
New +$101K
SAN icon
423
Banco Santander
SAN
$201B
$56K ﹤0.01%
+16,270
New +$55.1K
DMYI.WS
424
DELISTED
dMY Technology Group, Inc. III Redeemable warrants, each whole warrant exercisable for one share of
DMYI.WS
$56K ﹤0.01%
+24,420
New +$71.7K
BBVA icon
425
Banco Bilbao Vizcaya Argentaria
BBVA
$154B
$55K ﹤0.01%
10,474

Similar funds

Ingalls & Snyder LLC's Q1 2021 Portfolio in Review

As of Q1 2021, Ingalls & Snyder LLC held 461 positions worth $2.14B, up 5.8% from $2.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Ingalls & Snyder LLC's Q1 2021 filing shows 36 new, 115 increased, 195 reduced and 23 closed positions. Its largest new stake was JFrog: 68,342 shares worth $3.03M. The largest sale was Corcept Therapeutics, an estimated $9.49M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Technology and Financials.

  • Ingalls & Snyder LLC's largest Q1 2021 buy was JFrog: 68,342 shares worth $3.03M.
  • Ingalls & Snyder LLC added most to Deere & Co in Q1 2021, an estimated $4.94M increase.
  • Ingalls & Snyder LLC's biggest Q1 2021 reduction was Corcept Therapeutics, cutting an estimated $9.49M.
  • Ingalls & Snyder LLC fully exited Agenus in Q1 2021, selling an estimated $636K.
  • Ingalls & Snyder LLC's ten largest holdings make up 34% of its $2.14B portfolio in Q1 2021.
  • Ingalls & Snyder LLC opened 36 new positions and closed 23 in Q1 2021.
  • Ingalls & Snyder LLC's portfolio value rose 5.8% quarter-over-quarter to $2.14B.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2021, filed 21 Apr 2021.